Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC

BSE2355.7564.2 (+2.8 %)

PREV CLOSE ( ) 2291.55

OPEN PRICE ( ) 2359.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8620

TODAY'S LOW / HIGH ( )2340.00 2405.00

52 WK LOW / HIGH ( )1275.05 2649.95

NSE2359.5572.55 (+3.17 %)

PREV CLOSE( ) 2287.00

OPEN PRICE ( ) 2385.00

BID PRICE (QTY) 2359.55 (749)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 126099

TODAY'S LOW / HIGH( ) 2342.00 2401.35

52 WK LOW / HIGH ( )1277.1 2524

Quarters

Select year

( in Million)

Particulars

Mar 2024

Dec 2023

Sep 2023

Jun 2023

Audited / UnAudited

UnAudited

Net Sales

9298

8052.6

9569.9

7616.6

Total Expenditure

6725.4

5872

6675

6177.8

PBIDT (Excl OI)

2572.6

2180.6

2894.9

1438.8

Other Income

298.3

281.1

282.1

364.4

Operating Profit

2870.9

2461.7

3177

1803.2

Interest

7.7

3.2

4.3

2.8

Exceptional Items

-1633.1

173

PBDT

2887.2

825.40

3172.7

1973.4

Depreciation

181

171.1

181.1

163.6

Profit Before Tax

2706.2

654.30

2991.6

1809.8

Tax

761.4

197.1

816.5

487.3

Provisions and contingencies

Profit After Tax

1944.8

457.20

2175.1

1322.5

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

1944.8

457.20

2175.1

1322.5

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

1944.8

457.2

2175.1

1322.5

Equity Capital

1694.1

Face Value (IN RS)

Reserves

Calculated EPS

11.47

2.69

12.83

7.80

Calculated EPS (Annualised)

45.91

10.79

51.35

31.22

No of Public Share Holdings

42351510

% of Public Share Holdings

PBIDTM% (Excl OI)

27.66

27.07

30.25

18.89

PBIDTM%

30.87

30.57

33.19

23.67

PBDTM%

31.05

10.25

33.15

25.90

PBTM%

29.10

8.12

31.26

23.76

PATM%

20.91

5.67

22.72

17.36

Notes

Risk Disclosures on Derivatives

Quarterly Results

GLAXOSMITHKLINE PHARMACEUTICALS LTD.